Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIï¾® for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…
Humanigen expanded partnership with Catalent Biologics to manufacture investigational COVID-19 therapeutic candidate lenzilumab
On Jul. 16, 2020, Catalent and Humanigen announced the expansion of their relationship, under which Catalent will provide…
Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical iimes in US
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
Tonix Pharma announced research collaboration to develop precision medicine techniques for COVID-19 vaccines and therapeutics
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…
WHO and UNICEF warn of a decline in vaccinations during COVID-19
On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…
HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmission
On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…
BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…
Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinï¾’s Office of the…
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
On Jul. 14, 2020, a study by NIH researchers reported the placental membranes that contain the fetus and…
NIH researchers generated complete human X chromosome sequence
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the NIIH, announced…
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
CDC called on Americans to wear masks to prevent COVID-19 spread
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…
Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia
On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…
Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoï¾’s COVID-19 vaccine candidate
On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On Jul. 14, 2020, 3M and researchers at MIT announced they had started testing a new rapid test…
Celdara Medical announced the Pandemic Security Initiative
On Jul. 14, 2020, Celdara Medical announced the launch of its Pandemic Security Initiative, harnessing the resources needed…
Engineered llama antibodies neutralised Covid-19 virus
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
Junshi Biosciences and Lonza announced partnership to produce a neutralizing antibody tackling COVID-19
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sites
On Jul. 13, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced the enrollment of adult patients for…
Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
Deadly rabbit virus spread in the US
On Jul. 13, 2020, an emerging virus threatens both wild and pet rabbits in the U.S. The fatal…
Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDï¾™
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
Bellerophon Therapeutics announced first patient treated in phase 3 clinical study of INOpulseï¾® inhaled nitric oxide therapy for COVID-19
On Jul. 13, 2020, Bellerophon Therapeutics announced that the first patient has initiated treatment in the Companyï¾’s Phase…
Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesï¾’ four investigational vaccine candidates from…
OPKO Health’s BioReference Laboratories to provide COVID-19 testing for National Basketball Association players and employees
On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight…